Physician Innovator Webinar Series
The Future of Proteomics in Early Disease Detection
29 October 2025
7pm ET (45–60 minutes)
This session translates cutting-edge proteomics into clinical insight. We’ll discuss recent advances in protein measurement, compare leading platforms, and examine their impact on accuracy, scalability, and real-world use. The discussion will highlight key challenges and opportunities in developing novel diagnostics and screening tools, with examples from early detection, risk stratification, and surveillance—alongside practical considerations for workflow integration and clinical adoption.
Commercialization & Reimbursement Pathways
5 November 2025
7pm ET (45–60 minutes)
A concise roadmap from bench to bedside—covering regulatory strategy, commercialization, and payer engagement. We’ll outline the trade-offs between CLIA LDT and FDA pathways, how validation and evidence generation influence timelines, and what payers require to support coverage. Participants will gain a clear view of coding and reimbursement strategies, market access, and the economics of practice integration—providing both physicians and investors with a grounded understanding of how diagnostics reach patients.
Pipeline & Products
12 November 2025
7pm ET (45-60 minutes)
This final session offers a transparent update on Novelna’s R&D pipeline, product milestones, and near-term data readouts. We’ll discuss progress across validation studies, go-to-market priorities, and partnerships that will shape the next phase of growth. The session will also outline how physicians can engage to help accelerate the delivery of life-saving diagnostics to patients worldwide.
Submit your questions
Use the form below to share your questions or discussion topics for our upcoming sessions. We’ll do our best to incorporate as many as possible during the live Q&A.